Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

The diagnosis of brain metastasis (BrM) has historically been a dooming diagnosis that is nothing less than a death sentence, with few treatment options for palliation or prolonging life. Among the few treatment options available, brain radiotherapy (RT) and surgical resection have been the backbone of therapy. Within the past couple of years, immunotherapy (IT), alone and in combination with traditional treatments, has emerged as a reckoning force to combat the spread of BrM and shrink tumor burden. This review compiles recent reports describing the potential role of IT in the treatment of BrM in various cancers. It also examines the impact of the tumor microenvironment of BrM on regulating the spread of cancer and the role IT can play in mitigating that spread. Lastly, this review also focuses on the future of IT and new clinical trials pushing the boundaries of IT in BrM.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10349473PMC
http://dx.doi.org/10.1186/s12943-023-01818-7DOI Listing

Publication Analysis

Top Keywords

brain metastasis
8
treatment options
8
brm
5
immunotherapy emerging
4
emerging modality
4
modality checkmate
4
checkmate brain
4
metastasis diagnosis
4
diagnosis brain
4
metastasis brm
4

Similar Publications

Wearable device-measured circadian rest-activity rhythm with mortality risk in patients with cancer.

BMJ Health Care Inform

September 2025

Center for Sleep and Circadian Medicine, The Affiliated Brain Hospital, Guangzhou Medical University, Guangzhou, Guangdong, China

Objectives: The objectives were to examine the associations between accelerometer-measured circadian rest-activity rhythm (CRAR), the most prominent circadian rhythm in humans and the risk of mortality from all-cause, cancer and cardiovascular disease (CVD) in patients with cancer.

Methods: 7456 cancer participants from the UK Biobank were included. All participants wore accelerometers from 2013 to 2015 and were followed up until 24 January 2024, with a median follow-up of 9.

View Article and Find Full Text PDF

Intraoperative radiotherapy for resectable brain metastases: a systematic review and meta-analysis.

Radiother Oncol

September 2025

Department of Radiation Oncology, University Hospital Bonn, Bonn, Germany; Institute of Experimental Oncology, University Hospital Bonn, Bonn, Germany. Electronic address:

Background: In recent years, intraoperative radiotherapy (IORT) with low-energy X-rays is emerging as an alternative to postoperative stereotactic radiotherapy (SRT) of the resection cavity in patients with resectable brain metastases (BMs).

Methods: We performed a systematic review of the MEDLINE, Embase, and Scopus databases, including all original articles on IORT for resectable BMs from 2015 to 2025. Data on safety, local control, and survival outcomes were collected.

View Article and Find Full Text PDF

Staged Gamma Knife radiosurgery for large brain metastases: Local control and the influence of systemic treatment.

Radiother Oncol

September 2025

Amsterdam UMC, Location University of Amsterdam, Department of Neurosurgery, Meibergdreef 9, Amsterdam, the Netherlands; Amsterdam Neuroscience, Amsterdam, the Netherlands; Cancer Center Amsterdam, Amsterdam, the Netherlands.

Background And Purpose: Staged Gamma Knife radiosurgery (SGKRS) delivers high-dose radiotherapy to large brain metastases (BM) in two or three fractions with a time interval of several weeks. Various systemic treatments have also demonstrated favorable intracranial responses. Therefore, the outcome of patients undergoing radiosurgery and systemic treatment for large BM is of high interest but unknown.

View Article and Find Full Text PDF

Perturbing neural stem cell fate in glioblastoma heterogeneity and beyond.

Stem Cell Reports

September 2025

Laboratory of Neural Stem Cells and Functional Neurogenetics, Farmington, CT 06030, USA; Departments of Neuroscience, Neurology, Genetics and Genome Sciences, UConn Health, Farmington, CT 06030, USA. Electronic address:

Intratumoral heterogeneity in glioblastoma is thought to underlie its remarkable ability to recur and resist therapies. Its origins, however, remain unknown. In this issue, Liu et al.

View Article and Find Full Text PDF

CrossNeXt: ConvNeXt-based cross-teaching with entropy minimization for semi-supervised liver segmentation from abdominal MRI.

Comput Med Imaging Graph

August 2025

Academy for Engineering and Technology, Fudan University, Shanghai, 200433, People's Republic of China; Department of Radiology, Huashan Hospital, Fudan University, Shanghai, 200040, People's Republic of China; Shanghai Engineering Research Center of Intelligent Imaging for Critical Brain Diseases,

Recent advancements in artificial intelligence have significantly enhanced the efficiency of abdominal MRI segmentation, thereby improving the screening and diagnosis of liver diseases. However, accurate precise liver segmentation in MRI remains a challenging task due to the high variability in liver morphology and the limited availability of high-quality annotated datasets. To address these challenges, this study presents an advanced semi-supervised learning framework that integrates cross-teaching with pseudo-label generation and intra-batch entropy minimization.

View Article and Find Full Text PDF